SV

Sirgangari Venkat Reddy

Active Director Additional Director DIN 10310368
DIN 10310368 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sirgangari Venkat Reddy

Data last updated:

Sirgangari Venkat Reddy is an Additional Director at Invegose Labs Private Limited (since 2024). The company operates in Pharma.

DIN 10310368
Primary Designation Additional Director
Industry Pharma
First Appointment 31 Jan 2024
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Invegose Labs Private Limited U85100TG2022PTC167010
Additional Director31 Jan 20242022Active

Board colleagues of Sirgangari Venkat Reddy

Directorship timeline

Open interactive timeline →
Invegose Labs Private Limited
Premium access

Shareholding and investment profile for Sirgangari Venkat Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sirgangari Venkat Reddy

Sirgangari Venkat Reddy currently holds 1 directorship: Invegose Labs Private Limited (Additional Director, since 31 Jan 2024).

Sirgangari Venkat Reddy was first appointed on 31 Jan 2024 as Additional Director at Invegose Labs Private Limited.

The current boards of Sirgangari Venkat Reddy's companies include Addela Srilatha (Invegose Labs Private Limited), Indrapal Reddy Addela (Invegose Labs Private Limited), Srinivas Reddy Pulimamidi (Invegose Labs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available